Keyphrases
Bile
100%
Cholesterol
55%
Inflammatory Bowel Disease
49%
Cholesterol Crystallization
45%
Fatty Acid Bile Acid Conjugate
43%
Crohn's Disease
32%
Gallstones
29%
Helicobacter Pylori (H. pylori)
25%
Cannabis
24%
Gallbladder
22%
Chronic Liver Disease
20%
Human Bile
20%
Triple Therapy
19%
Nucleate
18%
Cholesterol Gallstones
18%
Endoscopic Retrograde Cholangiopancreatography
18%
Israel
18%
Ulcerative Colitis
18%
Colonoscopy
17%
Phospholipids
17%
Primary Sclerosing Cholangitis
17%
Non-alcoholic Fatty Liver Disease (NAFLD)
16%
Bile Acids
16%
Oral Administration
15%
Bile Salts
15%
Chronic Hepatitis C
15%
Crystallization
15%
Primary Biliary Cirrhosis
13%
Omeprazole
13%
Polyps
13%
Placebo
12%
Interferon-α (IFN-α)
12%
Cholecystectomy
12%
Cholesterol Crystals
12%
Fatty Liver
12%
Inflammation
12%
Cryptogenic Cirrhosis
11%
Risk Factors
11%
Liver Disease
11%
Disease Activity
11%
Aramchol
10%
Fatty Acids
10%
Enzyme-linked Immunosorbent Assay (ELISA)
10%
Lecithin
10%
Randomized Controlled Trial
10%
Duodenal Ulcer
10%
Helicobacter Pylori Infection
9%
Adenoma
9%
Colon
9%
Telomere
9%
Medicine and Dentistry
Bile
68%
Fatty Acid
28%
Gallstone
27%
Cannabis
25%
Bile Acid Conjugate
23%
Colonoscopy
22%
Endoscopic Retrograde Cholangiopancreatography
21%
Disease
20%
Inflammatory Bowel Disease
17%
Polyp
15%
Adenoma
13%
Helicobacter Pylori
13%
Placebo
13%
Cholecystectomy
13%
Cholesterol Stone
13%
Patient with Inflammatory Bowel Disease
12%
Disease Activity
12%
Malignant Neoplasm
11%
Colon
11%
Ulcerative Colitis
11%
Bile Duct
11%
Phospholipid
11%
Endoscopy
11%
Common Bile Duct Stone
11%
Fatty Liver
10%
Chronic Liver Disease
10%
Common Bile Duct
10%
Photodynamic Therapy
10%
Primary Sclerosing Cholangitis
10%
Diagnosis
9%
Cholelithiasis
9%
Crohn's Disease
9%
Bile Duct Stone
9%
Pylorus
9%
Bile Acid
8%
Side Effect
8%
Nonalcoholic Fatty Liver
8%
Polypeptide
8%
Bile Salt
8%
Liver Disease
8%
Endoscopic Sphincterotomy
8%
Surgery
8%
Liver Cirrhosis
8%
Cytotoxicity
8%
Oral Drug Administration
7%
Aminolevulinic Acid
7%
Combination Therapy
7%
Colorectal Cancer
7%
Patient with Crohn's Disease
7%
Symptom
7%
Pharmacology, Toxicology and Pharmaceutical Science
Fatty Acid
45%
Bile Acid Conjugate
44%
Cannabis
30%
Crohn's Disease
26%
Gallstone
26%
Disease
25%
Placebo
22%
Ulcerative Colitis
20%
Inflammatory Bowel Disease
19%
Mouse
19%
Fatty Liver
18%
Bile Acid
16%
Polyp
15%
Chronic Hepatitis C
15%
Cholesterol Stone
14%
Cholelithiasis
14%
Crystallization
13%
Side Effect
13%
Infection
12%
Symptom
11%
Remission
11%
Ursodeoxycholic Acid
10%
Chronic Liver Disease
10%
Omeprazole
10%
Randomized Controlled Trial
10%
Helicobacter Pylori
10%
Adenoma
10%
Duodenum Ulcer
10%
Cannabidiol
9%
Disease Activity
9%
Colorectal Cancer
8%
Interferon
8%
Nonalcoholic Fatty Liver
8%
Bile Salt
8%
Prevalence
7%
Combination Therapy
6%
Tinidazole
6%
Ribavirin
6%
Clarithromycin
6%
Pseudomembranous Colitis
6%
Nucleation
6%
Alpha Interferon
6%
Primary Biliary Cirrhosis
6%
Chemotherapy
5%
Liver Disease
5%
Inflammation
5%
Cannabinoid
5%
Placebo-Controlled Study
5%
Enzyme-Linked Immunosorbent Assay
5%
Hepatitis C
5%